"New drugs targeting other pathways could reassure those patients and give them hope." GLP-1 agonists are already under study for various health benefits beyond diabetes management, such as reducing heart disease risks and treating neurological conditions like Alzheimer's
SCL is CLIA-certified for high-complexity testing and is the pioneer of live-cell functional analysis
Some peptides survive the digestive tract and can be taken orally
Given the differences in the MedDRAs categorization rules, some potential PTs that were not included may exist, e.g., depression suicidal (belonging to HLGT level, depressed mood disorders and disturbances) and intentional overdose (belonging to HLGT level, overdoses, and underdoses NEC)
The most common side effects are nausea, vomiting, diarrhea, and stomach pain, including a potential fast heartbeat
Please note this only applies to recombinants labeled for use in bioassays